Results 241 to 250 of about 7,501,773 (380)

Prevalence of stroke in young adults in the Middle East and North Africa Region: A systematic review and meta-analysis. [PDF]

open access: yesPLOS Glob Public Health
Hegazi S   +7 more
europepmc   +1 more source

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

open access: yesJAMA Oncology, 2017
A. Dasari   +7 more
semanticscholar   +1 more source

Reply to: Commentary on “The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type”

open access: yes
Annals of Clinical and Translational Neurology, EarlyView.
Long Davalos   +2 more
wiley   +1 more source

Genetic Modifiers of Parkinson's Disease: A Case–Control Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the associations of LRRK2 p.G2019S, GBA1 p.N409S, polygenic risk scores (PRS), and APOE E4 on PD penetrance, risk, and symptoms. Methods We conducted a US‐based observational case–control study using data from the 23andMe Inc. and Fox Insight Genetic Substudy (FIGS) databases.
Matthew J. Kmiecik   +15 more
wiley   +1 more source

Primed by Prevalence

open access: yesJournal of the Royal College of Physicians of Edinburgh, 2019
openaire   +3 more sources

Prevalence of acne. [PDF]

open access: yesBMJ, 1979
B Dodman   +2 more
openaire   +3 more sources

Commentary on “The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type”

open access: yes
Annals of Clinical and Translational Neurology, EarlyView.
Majid Khalilizad   +4 more
wiley   +1 more source

Assessing a Mitochondrial Disease Treatment via a Novel Statistical Technique for Accelerometer Data

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Therapeutic development for mitochondrial diseases, rare genetic disorders with pathogenic defects of oxidative phosphorylation, is hindered by unsatisfactory outcome measures. To address this problem, we provide the first clinical application of a novel, bias‐adjusted outcome measure of acceleration across a range of subjects ...
Ian W. McKeague   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy